Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05651542 · ClinicalTrials.gov registry record · NA

A Comprehensive Self-Management Intervention for Individuals With Inflammatory Bowel Disease

A NA study of Ulcerative Colitis and Crohn Disease, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
55
Enrollment target
1
Study location

NCT05651542 is a NA study of Ulcerative Colitis and Crohn Disease that has completed, run by University of Washington. The registered enrollment target is 55 participants, below the 2,057-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05651542, a NA study of Ulcerative Colitis and Crohn Disease, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
55 participants
Enrollment target
1
Study location

Study Summary

This study aims to test the feasibility, acceptability, and preliminary efficacy of a comprehensive self-management (CSM) intervention for people with inflammatory bowel disease (IBD). The CSM-IBD intervention is an adaption of the CSM intervention initially developed for individuals with irritable bowel syndrome. The intervention has eight sessions which cover an introduction to IBD, symptom tracking, cognitive behavioral strategies, relaxation, sleep, diet, and pain management.

Interventions

  • OTHER Control
  • BEHAVIORAL Comprehensive Self-Management Intervention

Study Locations (1)

Washington

  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 55 participants
Start Date 2023-03-14
Est. Completion 2025-09-30
Phase NA

Sponsor

University of Washington

1,048 total trials

What the Registry Record Tells You About NCT05651542

The ClinicalTrials.gov registry entry for NCT05651542 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,057-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (97% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Ulcerative Colitis appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.

NCT05651542 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT05651542 about?

NCT05651542 is a clinical study titled "A Comprehensive Self-Management Intervention for Individuals With Inflammatory Bowel Disease". This study aims to test the feasibility, acceptability, and preliminary efficacy of a comprehensive self-management (CSM) intervention for people with inflammatory bowel disease (IBD). The CSM-IBD intervention is an adaption of the CSM intervention initially developed for individuals with irritable ...

What is the current status of trial NCT05651542?

This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2023-03-14. Estimated completion is 2025-09-30.

What conditions does trial NCT05651542 study?

This clinical trial studies the following conditions: Ulcerative Colitis, Crohn Disease, Inflammatory Bowel Diseases.

What interventions are being tested in trial NCT05651542?

The interventions under investigation include: Control (OTHER), Comprehensive Self-Management Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05651542?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05651542 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Ulcerative Colitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.